Skip to main content
Figure 4 | BMC Biochemistry

Figure 4

From: The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand

Figure 4

Effects of competitor peptides on thrombin clotting time. Diluted citrated human plasma was recalcified in the presence of thrombin and increasing concentrations of competitor peptides identified to the right of each line (either HCII 1-75 or HCII 54-75 (panel A) or sulfo-Hir 54-65 or Hir 55-65 (panel B)). The mean ± the SD of 3 independent experiments is shown.

Back to article page